IMARC Group, a leading market research company, has recently releases report titled “Cell and Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cell and gene therapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the cell and gene therapy market?
The global cell and gene therapy market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 43.0 Billion by 2028, exhibiting a growth rate (CAGR) of 17.4% during 2023-2028.
What is cell and gene therapy?
Cell and gene therapy are revolutionary medical treatments that utilize living cells and genetic material to treat or even cure diseases. Cell therapy involves the transplantation of healthy cells into a patient's body to replace or repair damaged tissues or cells.
Gene therapy, on the other hand, targets faulty or missing genes, allowing the introduction or alteration of genetic material within a patient's cells to correct or replace dysfunctional genes. These therapies offer promising prospects in treating various conditions, including genetic disorders, certain types of cancer, and autoimmune diseases.
Request for a sample report or buy full report: https://www.imarcgroup.com/cell-gene-therapy-market/requestsample
What are the growth prospects and trends in the cell and gene therapy industry?
The growing incidence of genetic disorders, cancers, and other chronic conditions is boosting demand for innovative treatments like cell and gene therapy which represents one of the key factors driving the growth of the cell and gene therapy market across the globe. In addition to this, improvement in healthcare facilities and increased accessibility to advanced treatments in developed and emerging economies are contributing to the market growth. The market is also driven by increasing awareness about the potential benefits of cell and gene therapies, along with patient acceptance.
In line with this, the increasing investment from both public and private sectors, including venture capital and pharmaceutical companies, is supporting research and development (R&D) activities which are fueling the growth of the market. Apart from this, the success of ongoing clinical trials and research in demonstrating the efficacy and safety of these therapies is driving the market confidence and expansion. The shift towards personalized and targeted therapeutic approaches is in alignment with the nature of cell and gene therapies, which is creating a positive outlook for the market across the globe.
Who are the key players operating in the industry?
The report covers the major market players including:
- Amgen Inc.
- Biogen
- Bluebird bio, Inc.
- Bristol-Myers Squibb
- Gilead Science
- Kolon TissueGene Inc.
- Orchard Therapeutics plc.
- Pfizer Inc
- Renova Therapeutics
- Spark Therapeutics, Inc.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapy Type:
- Cell Therapy
Stem Cell
Pluripotent Stem Cell
Cancer Stem Cell
Adult Stem Cell
Non-Stem Cell - T Cells
- Natural Killer
- Others
- Gene Therapy
Breakup by Indication:
- Cardiovascular Disease
- Oncology Disorder
- Genetic Disorder
- Infectious Disease
- Neurological Disorder
- Others
Breakup by Delivery Mode:
- In-Vivo
- Ex-Vivo
Breakup by End User:
- Hospitals
- Cancer Care Centers
- Pharmaceutical & Biotechnology Companies
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6964&flag=C\
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: https://twitter.com/ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/